ACM
ABBV icon

Advance Capital Management’s AbbVie ABBV Stock Holding History

Advance Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Buy
3,978
+912
+30% +$196K 0.03% 75
2026
Q1 		$667K Buy
3,066
+36
+1% +$7.99K 0.03% 92
2025
Q4 		$692K Buy
3,030
+23
+0.8% +$5.24K 0.03% 89
2025
Q3 		$696K Sell
3,007
-312
-9% -$63.5K 0.03% 89
2025
Q2 		$616K Buy
3,319
+5
+0.2% +$929 0.03% 94
2025
Q1 		$694K Sell
3,314
-4
-0.1% -$778 0.03% 80
2024
Q4 		$590K Buy
3,318
+66
+2% +$12.1K 0.03% 81
2024
Q3 		$642K Buy
3,252
+513
+19% +$95.7K 0.03% 79
2024
Q2 		$470K Sell
2,739
-163
-6% -$27K 0.02% 91
2024
Q1 		$528K Buy
2,902
+48
+2% +$8.27K 0.04% 82
2023
Q4 		$442K Sell
2,854
-141
-5% -$20.6K 0.03% 74
2023
Q3 		$446K Buy
2,995
+403
+16% +$59.2K 0.04% 72
2023
Q2 		$349K Buy
2,592
+815
+46% +$120K 0.04% 81
2023
Q1 		$283K Buy
1,777
+1
+0.1% +$153 0.05% 84
2022
Q4 		$287K Sell
1,776
-140
-7% -$21.5K 0.04% 82
2022
Q3 		$257K Buy
1,916
+228
+14% +$32.7K 0.03% 73
2022
Q2 		$259K Buy
1,688
+4
+0.2% +$611 0.03% 68
2022
Q1 		$273K Buy
1,684
+75
+5% +$10.9K 0.03% 69
2021
Q4 		$218K Buy
+1,609
New +$190K 0.04% 80

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Advance Capital Management's ABBV Position: Q2 2026 in Review

Advance Capital Management increased its AbbVie (ABBV) stake by 30% in Q2 2026, buying an estimated $196K and bringing the position to 3,978 shares worth $1M. The position accounts for 0.03% of the portfolio, ranked #75.

Advance Capital Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Advance Capital Management held 3,978 shares of AbbVie worth $1M as of Q2 2026.
  • Advance Capital Management bought 912 AbbVie shares in Q2 2026, an estimated $196K.
  • AbbVie made up 0.03% of Advance Capital Management's portfolio in Q2 2026, its #75 holding.
  • Advance Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Advance Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.